Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Transaction in Own Shares

4 Aug 2021 07:00

RNS Number : 4711H
Allied Minds PLC
04 August 2021
 

4 August 2021

 

Allied Minds

 

Transaction in own shares

 

Allied Minds plc (AIM:ALM, 'Allied Minds' or 'the Company') announces that, in accordance with the terms of its share buyback programme announced on 23 June 2021 ("Share Buyback Programme"), the Company purchased the following number of its Ordinary Shares of £0.01 each ("Ordinary Shares") through Numis Securities Limited. The Ordinary Shares purchased will be cancelled.

 

Date of purchase:

 3 August 2021

Aggregate number of Ordinary Shares purchased:

79,075

Lowest price paid per share (GBp):

20.100

Highest price paid per share (GBp):

20.500

Average price paid per share (GBp):

20.4642

 

Following the purchase of these shares, the remaining number of Ordinary Shares in issue will be 239,884,714 (excluding treasury shares), and the Company hold no Ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 239,884,714. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Numis Securities Limited as part of the Share Buyback Programme.

 

Schedule of Purchases - Individual Transactions

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

1756

20.50

08:37:42

00053036872TRLO0

LSE

485

20.50

13:27:59

00053050578TRLO0

LSE

5000

20.50

13:27:59

00053050580TRLO0

LSE

3093

20.50

13:27:59

00053050581TRLO0

LSE

6533

20.50

13:42:24

00053050996TRLO0

LSE

4498

20.50

13:42:24

00053050997TRLO0

LSE

6533

20.50

14:02:50

00053051672TRLO0

LSE

1240

20.50

14:02:50

00053051673TRLO0

LSE

6533

20.50

14:27:50

00053052481TRLO0

LSE

2182

20.50

14:27:50

00053052482TRLO0

LSE

6533

20.50

14:57:50

00053054359TRLO0

LSE

1823

20.50

14:57:50

00053054360TRLO0

LSE

1670

20.50

15:10:50

00053054902TRLO0

LSE

6202

20.50

15:10:50

00053054903TRLO0

LSE

331

20.50

15:29:50

00053056129TRLO0

LSE

7854

20.50

15:29:50

00053056130TRLO0

LSE

6533

20.50

15:39:50

00053056606TRLO0

LSE

2028

20.50

15:39:50

00053056607TRLO0

LSE

1130

20.50

15:46:12

00053056868TRLO0

LSE

43

20.50

15:47:44

00053056937TRLO0

LSE

7075

20.10

16:27:50

00053059058TRLO0

LSE

 

 

For more information, please contact:

 

Allied Minds plc

c/o Instinctif Partners

Harry Rein

Instinctif

alliedminds@instinctif.com

Tim Linacre / Rozi Morris / Hannah Campbell

 

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKZGGRVFDGMZM
Date   Source Headline
13th Nov 20174:42 pmRNSBlocklisting Six Monthly Return
13th Nov 20174:24 pmRNSBlocklisting Six Monthly Return
31st Oct 20174:47 pmRNSTotal Voting Rights
30th Oct 20177:00 amRNSAllied-Bristol Life Sciences forms ABLS IV
25th Oct 20177:00 amRNSAllied Minds Capital Markets Day: 18 January 2018
16th Oct 20177:59 amRNSAllied Minds: STT and TEL to jointly develop MRAM
6th Oct 20174:42 pmRNSTotal Voting Rights
5th Oct 20177:00 amRNSSTT announces $22.8m convertible bridge facility
28th Sep 20177:00 amRNSSciFluor SF0166 study positive top-line results
19th Sep 20177:00 amRNSDirectorate Change
14th Sep 20177:00 amRNSFederated Wireless $42m fundraise & product launch
13th Sep 20174:40 pmRNSSecond Price Monitoring Extn
13th Sep 20174:35 pmRNSPrice Monitoring Extension
1st Sep 201711:43 amRNSTotal Voting Rights
17th Aug 20177:00 amRNSHalf-year Report
8th Aug 20175:36 pmRNSHolding(s) in Company
2nd Aug 20177:00 amRNSNotice of Results
26th Jul 20177:00 amRNSALM subsid Signature Medical $2.5 million Series A
12th Jul 20177:00 amRNSBridgeSat, Inc. appoints Barry Matsumori as CEO
11th Jul 20174:35 pmRNSSpin Transfer Tech's appoints Tom Sparkman CEO
30th Jun 20175:29 pmRNSTotal Voting Rights
29th Jun 20177:00 amRNSAppointment of Head of Technology Investments
13th Jun 20177:05 amRNSDirector/PDMR Shareholding
13th Jun 20177:05 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
1st Jun 20175:02 pmRNSResult of AGM
30th May 20177:00 amRNSJill Smith Appointed As CEO and President
19th May 20174:58 pmRNSBlock Listing Six Monthly Return
12th May 20172:13 pmRNSBlock Listing of Shares
5th May 20177:00 amRNSBridgeSat raises $6 million in Series A financing
28th Apr 20173:14 pmRNSNotice of AGM; Annual Report
27th Apr 20177:00 amRNSAnnual Financial Report
20th Apr 20174:28 pmRNSHolding(s) in Company
18th Apr 20175:12 pmRNSHolding(s) in Company
7th Apr 20179:41 amRNSHolding(s) in Company
6th Apr 20175:24 pmRNSHolding(s) in Company
5th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20177:00 amRNSReallocation of capital and resources
31st Mar 20173:56 pmRNSTotal Voting Rights
16th Mar 20175:27 pmRNSHolding(s) in Company
13th Mar 20177:00 amRNSJill Smith appointed interim CEO of Allied Minds
1st Mar 20174:45 pmRNSTotal Voting Rights
15th Feb 20172:57 pmRNSHolding(s) in Company
14th Feb 20174:23 pmRNSTotal Voting Rights
7th Feb 20177:00 amRNSHawkEye 360 Completes Second Closing of Series A

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.